LEVERONE JASON A. (Chief Financial Officer) sold 1.8% of their position (302.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $896.25 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/23/2025ACC: 0001692747-25-000004
Officer· Chief Financial Officer
Since Oct 2024
-302.00
Net shares
Net seller
$896.25
Total sold
1
Open market trades
0B · 1S
1
Total transactions
302.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−302.00
Price / share
$2.97
Trade value
$896.25
% of position
1.8%
12/22/2025
16.60K→16.30K
Total
Net shares
−302.00
Net value
-$896.25
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/22/2025 | S · Sale | −302.00 | $2.97 | $896.25 | 1.8% | 16.60K | 16.30K |
| Total | −302.00 | -$896.25 | ||||||
Derivative Transactions0
No derivative transactions reported